About Us
Atombeat was founded by a passionate collective of scientists and innovators focused on the singular goal of democratizing computational tools for drug discovery.
Our platform is designed to tackle challenging targets and accelerate programs by harnessing cutting-edge AI- and physics-based models.
We believe that progress thrives when knowledge has no boundaries, and practice our commitment to open science by openly sharing findings and contributing to the life science community.
Product Milestones
Revamped Uni-FEP with enhanced performance and expanded functionalities.
RiDYMO™ platform successfully designs cyclic peptide targeting β-catenin, breaking through the limitations of natural amino acid.
Launched Uni-Dock v1.1, capable of screening 100 million ligands in just 8 hours and featured on NVIDIA's BioNeMo platform.
Launched Uni-Mol Docking v2, benchmarked against AlphaFold 3 as previous SOTA.
Announced RiDYMO™ platform and latest advancement in targing c-Myc.
Launched RiD module to solve the sampling challenge in modeling large biomolecules, published on Nature Computational Science.
Launched Uni-FEP module that enables protein-ligand affinity computation with leading chemical accuracy.
Launched Hermite® Computational Drug Discovery Platform.
Meet Our Team
Ready to accelerate your program?
Join Our Team
We're looking for passionate and dedicated teammates. Check out our job listings!
Our mission is to democratize computational drug discovery tools and empower researchers and organizations worldwide.